Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Símbolo de cotizaciónVVOS
Nombre de la empresaVivos Therapeutics Inc
Fecha de salida a bolsaDec 11, 2020
Director ejecutivoHuntsman (R. Kirk)
Número de empleados109
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 11
Dirección7921 Southpark Plaza,
CiudadLITTLETON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal80120
Teléfono18669084867
Sitio Webhttps://vivos.com/
Símbolo de cotizaciónVVOS
Fecha de salida a bolsaDec 11, 2020
Director ejecutivoHuntsman (R. Kirk)
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos